1. Home
  2. CERO vs ULY Comparison

CERO vs ULY Comparison

Compare CERO & ULY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • CERO
  • ULY
  • Stock Information
  • Founded
  • CERO 2017
  • ULY 2013
  • Country
  • CERO United States
  • ULY United States
  • Employees
  • CERO N/A
  • ULY N/A
  • Industry
  • CERO
  • ULY
  • Sector
  • CERO
  • ULY
  • Exchange
  • CERO Nasdaq
  • ULY Nasdaq
  • Market Cap
  • CERO 8.4M
  • ULY 6.7M
  • IPO Year
  • CERO N/A
  • ULY N/A
  • Fundamental
  • Price
  • CERO $1.78
  • ULY $0.50
  • Analyst Decision
  • CERO
  • ULY Strong Buy
  • Analyst Count
  • CERO 0
  • ULY 1
  • Target Price
  • CERO N/A
  • ULY $1.50
  • AVG Volume (30 Days)
  • CERO 764.0K
  • ULY 74.6K
  • Earning Date
  • CERO 02-20-2025
  • ULY 03-13-2025
  • Dividend Yield
  • CERO N/A
  • ULY N/A
  • EPS Growth
  • CERO N/A
  • ULY N/A
  • EPS
  • CERO N/A
  • ULY 7.18
  • Revenue
  • CERO N/A
  • ULY $155,926,000.00
  • Revenue This Year
  • CERO N/A
  • ULY N/A
  • Revenue Next Year
  • CERO N/A
  • ULY $4.29
  • P/E Ratio
  • CERO N/A
  • ULY $0.07
  • Revenue Growth
  • CERO N/A
  • ULY N/A
  • 52 Week Low
  • CERO $1.75
  • ULY $0.41
  • 52 Week High
  • CERO $1,238.00
  • ULY $3.45
  • Technical
  • Relative Strength Index (RSI)
  • CERO 32.86
  • ULY 49.13
  • Support Level
  • CERO $1.75
  • ULY $0.48
  • Resistance Level
  • CERO $2.22
  • ULY $0.54
  • Average True Range (ATR)
  • CERO 0.33
  • ULY 0.04
  • MACD
  • CERO 0.27
  • ULY 0.00
  • Stochastic Oscillator
  • CERO 4.90
  • ULY 56.14

About CERO CERo Therapeutics Holdings Inc. Common Stock

CERo Therapeutics Holdings Inc is an innovative immunotherapy company advancing the development of next-generation engineered T-cell therapeutics for the treatment of cancer. Its proprietary approach to T cell engineering, which enables it to integrate certain desirable characteristics of both innate and adaptive immunity into a single therapeutic construct, is designed to engage the body's full immune repertoire to achieve optimized cancer therapy.

About ULY Urgent.ly Inc.

Urgently Inc is a connected mobility assistance software platform, matching vehicle owners and operators with service professionals who deliver traditional roadside assistance, proactive maintenance and repair services. The traditional experience of a vehicle breakdown is often stressful and inconvenient, compounded by processes that lack transparency and lead to long wait times. Urgently offers an innovative alternative to this traditional experience, leveraging its digitally native software platform to match supply and demand in its network and deliver exceptional mobility assistance experiences at scale.

Share on Social Networks: